[Clinical Trial Results]: Positive data from Alzheimer's disease trials typically boosts stock price, while negative results often lead to a decline.

[Regulatory Approval]: Approval of Alzheimer's treatments by authorities like EMA significantly increases the stock's value; rejection decreases it.

[Competitor Activity]: News regarding competing Alzheimer's drug development from other companies can impact ALZCUR.ST's prospects and price.

[Market Sentiment]: Overall investor confidence and the general outlook for the pharmaceutical sector influence demand and stock valuation.

[Financial Performance]: Company's revenue, profitability, and cash flow affect investor perception and thereby the stock price.

[Patent Protection]: The strength and duration of patents on Alzheimer's treatments play a vital role in securing market exclusivity and influencing stock worth.

[Partnerships & Acquisitions]: Collaboration agreements or being acquired by larger pharmaceutical companies usually lead to higher stock prices.

[Economic Conditions]: Macroeconomic factors like interest rates and inflation rates can impact investment decisions and stock valuations.